0001127602-12-004603.txt : 20120208
0001127602-12-004603.hdr.sgml : 20120208
20120208130850
ACCESSION NUMBER: 0001127602-12-004603
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120207
FILED AS OF DATE: 20120208
DATE AS OF CHANGE: 20120208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INGRAM DOUGLAS S
CENTRAL INDEX KEY: 0001190644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10269
FILM NUMBER: 12580820
MAIL ADDRESS:
STREET 1: 2525 DUPONT DR
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALLERGAN INC
CENTRAL INDEX KEY: 0000850693
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 951622442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 7142464500
MAIL ADDRESS:
STREET 1: P.O. BOX 19534
CITY: IRVINE
STATE: CA
ZIP: 92713-9534
4
1
form4.xml
PRIMARY DOCUMENT
X0304
4
2012-02-07
0000850693
ALLERGAN INC
AGN
0001190644
INGRAM DOUGLAS S
2525 DUPONT DRIVE
IRVINE
CA
92612
1
EVP and President, EAME
Common Stock
2012-02-07
4
M
0
66000
41.24
A
89814.176
D
Common Stock
2012-02-07
4
S
0
66000
86.3747
D
23814.176
D
Common Stock
2662.2215
I
By 401(k) Trust
Common Stock
3596.7989
I
By Esop Trust
Employee Stock Option (Right to Buy)
41.24
2012-02-07
4
M
0
66000
0
D
2014-01-30
Common Stock
66000
0
D
The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.25 to $86.53, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
Shares allocated to reporting person's SIP account as of reporting date.
Shares allocated to the reporting person's ESOP account as of reporting date.
The option becomes exercisable in four equal annual installments beginning January 30, 2005.
/s/ Matthew J. Maletta, attorney-in-fact for Douglas S. Ingram
2012-02-07